- STAT+: U.S. judge blocks Colorado’s first-of-its-kind price cap on an Amgen drugA federal judge blocked a Colorado state panel from placing a cap on the price of Enbrel, a blockbuster drug sold by AmgenSTAT · 24d ago↗ source
- STAT+: More frequent, more intense, and longer heat waves pose health risks for AmericansThe presidential fitness test is back, surprising new data on the health risks of obesity, and more Morning Rounds newsSTAT · 24d ago↗ source
- Roche’s KRAS G12C inhibitor beats rivals in head-to-head Phase 3 studyRoche’s lung cancer drug candidate divarasib has beaten marketed drugs from Amgen and Bristol Myers Squibb in a head-to-head trial. Full data haven't yet emerged, but if the drug's survival benefit…